Back
Monte Rosa Therapeutics Stock Predictions

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
46
GLUE
Monte Rosa Therapeutics
Last Price:
$5.00
Seasonality Move:
-6.12%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report NowMonte Rosa Therapeutics Stock Forecast
-
Is Monte Rosa Therapeutics Stock Undervalued?The current Monte Rosa Therapeutics [GLUE] share price is $4.87. The Score for GLUE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Monte Rosa Therapeutics Stock Go Up Next Year?
Data Unavailable
Monte Rosa Therapeutics Stock Rating
Data Unavailable
Monte Rosa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monterosatx.com
52-Week Data
52-Week High:
12.40
52-Week Low:
3.50
Prediction Charts
Market Cap:
299.6M
Price in USD:
4.87
Volume:
198.9K
Beta:
1.44
Technical Analysis
SMA50:
4.53
SMA100:
5.04
SMA200:
6.01
52-Wk Change:
25.19%
Stock Predictions
-
Is Monte Rosa Therapeutics stock public?Yes, Monte Rosa Therapeutics is a publicly traded company.
-
What is the Monte Rosa Therapeutics stock quote today?The Monte Rosa Therapeutics stock price is 4.87 USD today.
-
How to buy Monte Rosa Therapeutics stock online?You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-16 | 5.01 | 4.82 | 5.11 | 4.66 |
Jun-17 | 4.87 | 4.57 | 4.94 | 4.57 |
Jun-18 | 4.56 | 4.49 | 4.68 | 4.41 |
Jun-20 | 4.63 | 4.63 | 4.66 | 4.37 |
Jun-23 | 4.61 | 4.64 | 4.65 | 4.46 |
Jun-24 | 4.67 | 4.74 | 4.85 | 4.61 |
Jun-25 | 4.74 | 4.77 | 4.82 | 4.47 |
Jun-26 | 4.77 | 4.66 | 4.77 | 4.59 |
Jun-27 | 4.68 | 4.60 | 4.71 | 4.52 |
Jun-30 | 4.57 | 4.51 | 4.70 | 4.50 |
Jul-1 | 4.50 | 4.61 | 4.66 | 4.42 |
Jul-2 | 4.61 | 4.73 | 4.84 | 4.59 |
Jul-3 | 4.79 | 4.87 | 4.88 | 4.64 |
Jul-7 | 4.85 | 4.97 | 5.13 | 4.73 |
Monte Rosa Therapeutics Earnings
Data Unavailable
Monte Rosa Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.82 per share, and a decrease next year of $0.99 per share.
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.